skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Select Catalysts from Last Quarter's Outlook Report

What were the outcomes of critical catalysts featured in Biomedtracker’s Q3 2019 Outlook Report? Find out in the Catalyst Roundup: A Review of Select Catalysts from Last Quarter’s Outlook Report. This data-rich graphic is available now – for free. 

This vital infographic contains critical data about Golodirsen for Duchenne Muscular Dystrophy (DMD), Recarbrio for Intra-Abdominal Infections, and Recarbrio for Urinary Tract and Reproductive Tract Infections, including: 
The catalyst that occurred
Trial results
Biomedtracker’s Likelihood of Approval (LOA) analysis
5-day stock performance surrounding the catalyst event
Other notable upcoming catalysts for the drugs
Reactions from SAGE and Aevi Genomic 


Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free   : +1 888 670 8900  
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (20) 805 20700
  • Australia        : +61 2 8705 6907

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: